Patents by Inventor Marco Soriani

Marco Soriani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mutant bacteria for production of generalized modules for membrane antigens
    Patent number: 10864262
    Abstract: Gram-negative bacterial strains are generated by inactivating at least one LytM catalytic domain-containing protein, such as NT013, NT017 and NT022 of non typeable H influenzae. The vesicles from these strains are useful for vaccination.
    Type: Grant
    Filed: April 24, 2014
    Date of Patent: December 15, 2020
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Maria Arico, Giuseppe Ercoli, Nathalie Norais, Marco Soriani, Chiara Tani
  • ANTIGENS AND ANTIGEN COMBINATIONS
    Publication number: 20190290748
    Abstract: NTHI protein antigens have been identified and found to be conserved across several Haemophilus influenzae pathogenic strains. They have been isolated, cloned from a reference strain and tested for immunogenicity. Methods for immunization and vaccines derived thereof are also disclosed.
    Type: Application
    Filed: March 25, 2019
    Publication date: September 26, 2019
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Marco SORIANI, Maria SCARSELLI, Nathalie NORAIS, Danilo GOMES MORIEL, Silvia ROSSI PACCANI
  • Antigens and antigen combinations
    Patent number: 10279026
    Abstract: NTHI protein antigens have been identified and found to be conserved across several Haemophilus influenzae pathogenic strains. They have been isolated, cloned from a reference strain and tested for immunogenicity. Methods for immunization and vaccines derived thereof are also disclosed.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: May 7, 2019
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Marco Soriani, Maria Scarselli, Nathalie Norais, Danilo Gomes Moriel, Silvia Rossi Paccani
  • MUTANT BACTERIA FOR PRODUCTION OF GENERALIZED MODULES FOR MRMBRANE ANTIGENS
    Publication number: 20160067326
    Abstract: Gram-negative bacterial strains are generated by inactivating at least one LytM catalytic domain-containing protein, such as NT013, NT017 and NT022 of non typeable H influenzae. The vesicles from these strains are useful for vaccination.
    Type: Application
    Filed: April 24, 2014
    Publication date: March 10, 2016
    Applicant: GlaxoSmithKline Biologicals s.a.
    Inventors: Maria ARICO, Giuseppe ERCOLI, Nathalie NORAIS, Marco SORIANI, Chiara TANI
  • ANTIGENS AND ANTIGEN COMBINATIONS
    Publication number: 20150202279
    Abstract: NTHI protein antigens have been identified and found to be conserved across several Haemophilus influenzae pathogenic strains. They have been isolated, cloned from a reference strain and tested for immunogenicity. Methods for immunization and vaccines derived thereof are also disclosed.
    Type: Application
    Filed: April 24, 2013
    Publication date: July 23, 2015
    Inventors: Marco Soriani, Maria Scarselli, Nathalie Norais, Danilo Gomes Moriel, Silvia Rossi Paccani
  • Serum resistance factors of gram positive bacteria
    Patent number: 8377446
    Abstract: A newly identified serum resistance factor of gram positive bacteria can be used to treat or prevent bacterial infection.
    Type: Grant
    Filed: December 16, 2011
    Date of Patent: February 19, 2013
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Marco Soriani, Isabella Santi
  • SERUM RESISTANCE FACTORS OF GRAM POSITIVE BACTERIA
    Publication number: 20120171211
    Abstract: A newly identified serum resistance factor of gram positive bacteria can be used to treat or prevent bacterial infection.
    Type: Application
    Filed: December 16, 2011
    Publication date: July 5, 2012
    Inventors: Marco Soriani, Isabella Santi
  • Serum resistance factors of gram positive bacteria
    Patent number: 8105612
    Abstract: A newly identified serum resistance factor of gram positive bacteria can be used to treat or prevent bacterial infection.
    Type: Grant
    Filed: May 12, 2006
    Date of Patent: January 31, 2012
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Marco Soriani, Isabella Santi
  • Serum Resistance Factors of Gram Positive Bacteria
    Publication number: 20090214537
    Abstract: A newly identified serum resistance factor of gram positive bacteria can be used to treat or prevent bacterial infection.
    Type: Application
    Filed: May 12, 2006
    Publication date: August 27, 2009
    Applicant: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
    Inventors: Marco Soriani, Isabella Santi